A detailed history of Providence Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 13,005 shares of ABBV stock, worth $2.15 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares
13,005
Previous 13,354 2.61%
Holding current value
$2.15 Million
Previous $2.29 Million 12.14%
% of portfolio
1.91%
Previous 1.84%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $57,180 - $69,566
-349 Reduced 2.61%
13,005 $2.57 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $29,100 - $33,982
188 Added 1.43%
13,354 $2.29 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $33,881 - $38,605
212 Added 1.64%
13,166 $2.4 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $54,638 - $63,251
-409 Reduced 3.06%
12,954 $1.93 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $79,108 - $98,445
-597 Reduced 4.28%
13,363 $1.8 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $58,856 - $67,781
-407 Reduced 2.83%
13,960 $2.22 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $24,480 - $29,358
177 Added 1.25%
14,367 $2.32 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $81,733 - $93,743
609 Added 4.48%
14,190 $2.13 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $136,519 - $173,560
992 Added 7.88%
13,581 $2.06 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $123,665 - $153,433
-937 Reduced 6.93%
12,589 $2.05 Million
Q4 2021

Jan 12, 2022

BUY
$107.43 - $135.93 $215,826 - $273,083
2,009 Added 17.44%
13,526 $1.83 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $119,912 - $136,119
-1,127 Reduced 8.91%
11,517 $1.25 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $14,098 - $15,706
134 Added 1.07%
12,644 $1.46 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $98,514 - $108,453
963 Added 8.34%
12,510 $1.35 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $97,714 - $131,925
1,214 Added 11.75%
11,547 $1.22 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $397,591 - $466,641
4,628 Added 81.12%
10,333 $905,000
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $150,701 - $201,661
2,054 Added 56.26%
5,705 $560,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $8,643 - $13,103
134 Added 3.81%
3,651 $265,000
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $577 - $722
8 Added 0.23%
3,517 $311,000
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $220,996 - $265,701
3,509 New
3,509 $266,000
Q2 2019

Jul 22, 2019

SELL
$65.7 - $83.98 $215,298 - $275,202
-3,277 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$77.14 - $90.79 $462 - $544
6 Added 0.18%
3,277 $263,000
Q4 2018

Feb 04, 2019

SELL
$77.85 - $96.01 $22,965 - $28,322
-295 Reduced 8.27%
3,271 $298,000
Q3 2018

Nov 01, 2018

BUY
$88.91 - $98.84 $444 - $494
5 Added 0.14%
3,566 $337,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $22,893 - $27,088
255 Added 7.71%
3,561 $330,000
Q1 2018

Aug 14, 2018

BUY
$92.01 - $123.21 $304,185 - $407,332
3,306 New
3,306 $302,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Providence Wealth Advisors, LLC Portfolio

Follow Providence Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.